These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 10877115)

  • 1. Subchronic fluoxetine treatment induces a transient potentiation of amphetamine-induced hyperlocomotion: possible pharmacokinetic interaction.
    Sills TL; Greenshaw AJ; Baker GB; Fletcher PJ
    Behav Pharmacol; 2000 Apr; 11(2):109-16. PubMed ID: 10877115
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The potentiating effect of sertraline and fluoxetine on amphetamine-induced locomotor activity is not mediated by serotonin.
    Sills TL; Greenshaw AJ; Baker GB; Fletcher PJ
    Psychopharmacology (Berl); 1999 Apr; 143(4):426-32. PubMed ID: 10367561
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute fluoxetine treatment potentiates amphetamine hyperactivity and amphetamine-induced nucleus accumbens dopamine release: possible pharmacokinetic interaction.
    Sills TL; Greenshaw AJ; Baker GB; Fletcher PJ
    Psychopharmacology (Berl); 1999 Feb; 141(4):421-7. PubMed ID: 10090650
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential effects of withdrawal from chronic amphetamine or fluoxetine administration on brain stimulation reward in the rat--interactions between the two drugs.
    Lin D; Koob GF; Markou A
    Psychopharmacology (Berl); 1999 Aug; 145(3):283-94. PubMed ID: 10494577
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fluoxetine, but not sertraline or citalopram, potentiates the locomotor stimulant effect of cocaine: possible pharmacokinetic effects.
    Fletcher PJ; Sinyard J; Salsali M; Baker GB
    Psychopharmacology (Berl); 2004 Jul; 174(3):406-13. PubMed ID: 14740149
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The synergistic effect of fluoxetine on the locomotor hyperactivity induced by MK-801, a non-competitive NMDA receptor antagonist.
    Maj J; Rogóz Z; Skuza G; Wedzony K
    J Neural Transm (Vienna); 1996; 103(1-2):131-46. PubMed ID: 9026367
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metyrapone and fluoxetine suppress enduring behavioral but not cardiac effects of subchronic stress in rats.
    Carnevali L; Bondarenko E; Sgoifo A; Walker FR; Head GA; Lukoshkova EV; Day TA; Nalivaiko E
    Am J Physiol Regul Integr Comp Physiol; 2011 Oct; 301(4):R1123-31. PubMed ID: 21795640
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fluoxetine combined with a serotonin-1A receptor antagonist reversed reward deficits observed during nicotine and amphetamine withdrawal in rats.
    Harrison AA; Liem YT; Markou A
    Neuropsychopharmacology; 2001 Jul; 25(1):55-71. PubMed ID: 11377919
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fluoxetine and aripiprazole treatment following prenatal immune activation exert longstanding effects on rat locomotor response.
    Richtand NM; Ahlbrand R; Horn P; Tambyraja R; Grainger M; Bronson SL; McNamara RK
    Physiol Behav; 2012 May; 106(2):171-7. PubMed ID: 22342193
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fluoxetine potentiation of methylphenidate-induced neuropeptide expression in the striatum occurs selectively in direct pathway (striatonigral) neurons.
    Van Waes V; Carr B; Beverley JA; Steiner H
    J Neurochem; 2012 Sep; 122(5):1054-64. PubMed ID: 22738672
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Central administration of p-hydroxyamphetamine produces a behavioral stimulant effect in rodents: evidence for the involvement of dopaminergic systems.
    Onogi H; Hozumi M; Nakagawasai O; Arai Y; Ishigaki S; Sato A; Furuta S; Niijima F; Tan-No K; Tadano T
    Psychopharmacology (Berl); 2010 Feb; 208(2):323-31. PubMed ID: 19960188
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduced efficacy of fluoxetine following MDMA ("Ecstasy")-induced serotonin loss in rats.
    Durkin S; Prendergast A; Harkin A
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Dec; 32(8):1894-901. PubMed ID: 18824064
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of fluoxetine and norfluoxetine on 5-hydroxytryptamine metabolism in blood platelets and brain after administration to rats.
    Bourdeaux R; Desor D; Lehr PR; Younos C; Capolaghi B
    J Pharm Pharmacol; 1998 Dec; 50(12):1387-92. PubMed ID: 10052854
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fluoxetine attenuates morphine-induced locomotion and blocks morphine-sensitization.
    Sills TL; Fletcher PJ
    Eur J Pharmacol; 1997 Oct; 337(2-3):161-4. PubMed ID: 9430410
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potentiation of amphetamine-mediated responses in caffeine-sensitized rats involves modifications in A2A receptors and zif-268 mRNAs in striatal neurons.
    Tronci E; Simola N; Carta AR; De Luca MA; Morelli M
    J Neurochem; 2006 Aug; 98(4):1078-89. PubMed ID: 16771831
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fluoxetine potentiation of omega-3 fatty acid antidepressant effect: evaluating pharmacokinetic and brain fatty acid-related aspects in rodents.
    Laino CH; Garcia P; Podestá MF; Höcht C; Slobodianik N; Reinés A
    J Pharm Sci; 2014 Oct; 103(10):3316-25. PubMed ID: 25174836
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 5-HT 1B receptor-mediated serotoninergic modulation of methylphenidate-induced locomotor activation in rats.
    Borycz J; Zapata A; Quiroz C; Volkow ND; Ferré S
    Neuropsychopharmacology; 2008 Feb; 33(3):619-26. PubMed ID: 17487226
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Subchronic MK-801 treatment and post-weaning social isolation in rats: differential effects on locomotor activity and hippocampal long-term potentiation.
    Ashby DM; Habib D; Dringenberg HC; Reynolds JN; Beninger RJ
    Behav Brain Res; 2010 Sep; 212(1):64-70. PubMed ID: 20382186
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Subchronic elevation of brain kynurenic acid augments amphetamine-induced locomotor response in mice.
    Olsson SK; Larsson MK; Erhardt S
    J Neural Transm (Vienna); 2012 Feb; 119(2):155-63. PubMed ID: 21904895
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Involvement of serotonin in the modulation of cocaine-induced locomotor activity in the rat.
    Herges S; Taylor DA
    Pharmacol Biochem Behav; 1998 Mar; 59(3):595-611. PubMed ID: 9512061
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.